Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buqi Tongluo Granules in Qi Deficiency and Blood Stasis Syndrome
CTR20192277Phase 2Completed
- Sponsor
- Buchang Pharmaceuticals
- Start
- May 2020
- Countries
- 1
01
Overview
A Phase 2 trial of Buqitongluo Granule in syndrome, ischemic stroke, coronary arteriosclerosis, diabetic polyneuropathy (DPN), sponsored by Buchang Pharmaceuticals. Started May 2020; status: completed.
02
Drugs
Buqitongluo Granule
03
Conditions
syndromeischemic strokecoronary arteriosclerosisdiabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20192277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192277.